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Clear cell tumor of the lung is a rare and benign pulmonary tumor; only sporadic cases have been reported. Here,
we report the case of a 38-year-old man with recurrent cough, blood-streaked sputum and left chest pain. A chest
computed tomography scan showed a round, homogeneous pulmonary mass in the left lower lobe, which
exhibited intense heterogeneous enhancement in the arterial phase and homogeneous in the delay phase after
injecting a contrast agent. The patient underwent a fine-needle aspiration biopsy and was diagnosed as having a
benign clear cell tumor of the lung. The clinical presentation and radiographic investigation of this tumor are
summarized in this paper to recognize this rare disease. Interestingly, we found some differences with previously
reported cases.
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Clear cell tumor of the lung (CCTL) is a rare and benign
pulmonary neoplasm, which was originally described by
Liebow and Castleman in 1963 [1]. CCTL most likely
arises from perivascular epithelioid cells (PECs) [2-4]. As
it contains abundant cytoplasmic periodic acid-Schiff
(PAS)-positive glycogen, CCTL has been termed “sugar
tumor” [5]. The tumor cells show immunoreactivity for
the S-100 protein and HMB-45 and no cytokeratin
reactivity, which establish a definitive diagnosis [6].
Although the tumor has been well defined, only sporadic
cases have been reported in the literature. Here, we report
on a CCTL case and summarize a literature review of 55
CCTL cases. Our aims were to identify the clinical and
radiological features of CCTL and determine the effect of
CCTL tumor size.Case presentation
A 38-year-old man was admitted to our hospital because
of recurrent cough, blood-streaked sputum for 2 months,
left chest pain for 10 days, and worsening health for
3 days. The patient, who had no known family history
of cancer, was an 18 pack/year smoker. He did not* Correspondence: xqwgxll@163.com
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reproduction in any medium, provided the orreport any fever, night sweating, chest tightness, weight
loss, or wheezing. A physical examination did not show
any abnormalities, and the results of laboratory studies
were unremarkable. Chest non-enhanced computed
tomography (CT) scans showed a demarcated, round,
homogeneous lesion of approximately 3.4 cm in diameter
without evidence of calcification, necrosis, cavitation, or
satellite lesions in the left lower lobe (Figure 1A), with a
CT value of 46.6 Hounsfield units. A contrast-enhanced
CT scan of the solitary pulmonary mass showed intense
heterogeneous enhancement in the arterial phase
(Figure 1B) and a homogeneous nature in the delay
phase (delay 150 seconds) (Figure 1C). Abdominal CT
scans showed no evidence of renal disease.
Using an 18-gauge needle, a CT-guided biopsy of the
lung at our institution was performed to determine the
nature of the lesion. Light microscopy and immuno-
histochemical studies were performed. The material for
pathological examination that was obtained at the biopsy
was fixed in 10% formalin and embedded in paraffin. For
light microscopy, 5-μm thick sections were cut from the
inclusions and stained with hematoxylin and eosin and
PAS. For PAS staining, the slide was fixed with 4% para-
formaldehyde, oxidized in 1% periodic acid for 5 minutes
and then washed and treated with Schiff ’s reagent for 15
minutes. The slide was subsequently treated for color
development in dH2O for 5 to 10 minutes and assessedtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Figure 1 Chest computed tomography findings of the tumor. (A) Chest plain computed tomography scan shows a solitary, rounded,
smooth-surfaced, homogenous density mass of approximately 3.4 cm in diameter in the left lower lobe (S6). (B) The contrast-enhanced arterial
phase shows intense heterogeneous enhancement measuring 67.2 to 128.0 Hounsfield units. (C) The contrast-enhanced delay phase shows an
isodense nodule measuring 66.3 Hounsfield units.
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affin sections were treated with monoclonal antibodies
against HMB-45, vimentin, CD34, S-100 protein, cyto-
keratin, desmin, CD68, EMA, RCC, and TTF-1. The
antigen-antibody complexes were visualized using the
streptavidin-biotin-peroxidase complex method.
Histologically, the lesion consisted of sheets of neoplas-
tic cells. Plump, short, polygonal, and spindle-shaped cells
with distinctive cell borders and mildly pleiomorphic
nuclei were observed. These cells were surrounded by
thin-walled blood vessels of various sizes (Figure 2A).
No signs of necrosis and no mitotic figures were seen.
The clear cytoplasm contained numerous glycogen
granules, as demonstrated by PAS stain (Figure 2B). The
immunohistochemical studies showed strong immunore-
activity for HMB-45 (Figure 2C) and showed a positive
reaction to vimentin, CD34, and S-100 protein but no
reactivity for cytokeratin, desmin, CD68, EMA, RCC,
and TTF-1. Based on these findings, the lesion was
diagnosed as CCTL. The patient underwent a left thora-
cotomy, and a wedge resection was performed to remove
the tumor, whose pathologic findings were concordantFigure 2 Microscopic and immunohistochemistry findings. (A) Histopa
with abundant clear cytoplasm, distinctive cell borders, and thin-walled blo
cells have intracytoplasmic periodic acid-Schiff-positive glycogen granules
staining for HMB-45 (streptavidin-perosidase, ×200).with the biopsy specimen. No evidence of recurrence or
metastatic disease was evident during the 12-month
follow-up period after the surgery.
Literature review
PubMed and Google were searched in March 2012 using
the following terms in various combinations: benign
lung tumor, clear cell tumor, sugar tumor, CCTL and
PEComa. Only full-text English studies were reviewed.
A total of 56 CCTL cases (including the present case)
were reviewed [2,4,6-27]. The collected data included
patient age, gender, symptoms, and tumor location,
contour, and density. Table 1 illustrates the clinical char-
acteristics of the CCTL patients and radiological features
of the tumors. The relationships between tumor size and
the parameters of symptoms, location, contour, and dens-
ity were assessed with Spearman’s correlation. The statis-
tical differences in symptoms and tumor contour were
compared between the ≥2.2 cm tumor size group and
the <2.2 cm tumor size group using the chi-squared test.
Statistical analyses were performed with the Statistical
Package for the Social Sciences (SPSS, Chicago IL, U.S.A;thological examination shows diffuse growth of rounded or oval cells
od vessels (hematoxylin and eosin, ×200. (B) Most neoplastic clear
(streptavidin-perosidase, ×200. (C) Many tumor cells show cytoplasmic






























LU, left upper lobe; LL, left lower lobe; RU, right upper lobe; RM, right middle
lobe; RL, right lower lobe; NR, not recorded.
Table 3 Correlation between tumor size and symptoms
Size Asymptomatic* Symptomatic Total
<2.2 cm 25 4 29
≥2.2 cm 12 15 27
*Four cases with symptoms that were not necessarily connected with CCTL
were classified as asymptomatic.
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Spearman’s correlation analysis showed that tumor
size was most frequently associated with symptoms and
tumor contours (Table 2), whereas it has no significant
correlation with location and density (Table 2). There were
significant statistical differences in patient symptoms andTable 2 Correlation between tumor size and symptoms,
location, contour, and density




Density 0.052 0.702tumor contour between the ≥2.2 cm group and the <2.2
cm group. Patients were more likely to experience symp-
toms (chi2 = 56.000, P = 0.000, Table 3), and the tumor
was more likely to be lobulated (chi2 = 72.333, P = 0.000,
Table 4) if the tumor size was ≥2.2 cm.
Discussion
CCTL is a rare benign pulmonary neoplasm originally
described in 1963 by Liebow and Castleman [1]. Since
that time, fewer than 60 cases have been reported in the
English literature. CCTL can occur in any age group
(range 8 to 73 years), with equal sex prevalence
[7,8,10,16,17,23,25,26] or a slight female predominance
[4,9,14,24,28]. However, in our study, males were
slightly more prone to CCTL than females (29/27).
Most patients were asymptomatic; only a few patients
displayed symptoms (for example, chest pain, back pain,
breathlessness, sense of suppression, cough, pneumonia,
fever, bloody sputum or hemoptysis) [6-15,24]. These
symptoms were usually nonspecific, as most cases were
discovered incidentally on routine chest radiographs or
CT scans.
Radiographically, CCTL presents as a rounded, smooth-
walled peripheral parenchymal nodule, without evidence
of cavitation or calcification. There are no specific lobar
distributions according to the literature [7,8,16,17]. In our
study, nodules were generally found in the lower lobes of
both lungs (32/52) and were unrelated to vessels or major
bronchi. The tumor sizes ranged from 1 mm [29] to
12 cm [10]. In our literature review, we found that certain
clinicopathologic features such as a diameter >2.5 cm, the
presence of symptoms, and extensive necrosis or abundant
mitoses visible under an optical microscope were asso-
ciated with more aggressive behavior [13,17,21,27]. Our
results showed that the tumor size was most closely corre-
lated with patients’ symptoms and tumor contour: signifi-
cant statistical differences were found between the ≥2.2
cm group and the <2.2 cm group. The results suggested
that patients should undergo operation or follow-up if the
tumor size was ≥2.2 cm. However, the lesion density was
not correlated with tumor size.Table 4 Correlation between tumor size and contour
Size Round Lobulated NR Total
<2.2 cm 24 0 5 29
≥2.2 cm 15 5 7 27
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features of this case were the intense heterogeneous
enhancement in the arterial phase and washout in the
delay phase, which were consistent with a previous
report [17]. This CT finding appears to be a result of
the vascular stroma [8,13,17,24], although occasionally,
for an unknown reason, there is no enhancement [22].
The characteristics of CCTL, which have been described
as having an intense heterogeneous enhancement in the
arterial phase and homogeneous in the delay phase,
have not been previously reported. The CT enhance-
ment features indicate the malignant potential of this
mass rather than a benign nodule [17]. The preoperative
accurate CT diagnosis of this disease is difficult.
CCTL is usually diagnosed by thoracotomy, lobectomy,
and segmentectomy. Partial resection and enucleation
have been reported as treatments in previous studies [22].
Only one case of CCTL was diagnosed pre-operatively by
a transbronchial lung biopsy [19], and three cases (includ-
ing the case reported here) by fine-needle aspiration
biopsy [9,23]. The biology of this tumor has traditionally
been considered benign, but malignant behavior has been
occasionally reported. A 1988 report described a patient
with CCTL who died from metastatic CCTL [30], and two
other reports described this tumor with rapid growth
[5,26]. Our patient was a heavy smoker with a lung mass,
which exhibited an intense post-contrast enhancement in
the arterial phase and washout in the delay phase on CT
scan and was considered to have a malignant potential.
Surgical treatment was suggested.
Macroscopically, CCTL predominantly appears as well-
circumscribed, peripheral nodules measuring ≤3 cm in
diameter; cut surfaces are typically homogeneous and
glistening, without evidence of hemorrhage, necrosis,
cavitation, or calcification [8,17]. Histologically, the
nodules are composed of mitotically inactive round or oval
cells with clear or granular eosinophilic cytoplasm and
distinct cell borders, with characteristic intervening thin-
walled sinusoidal vessels; spindle cells may be observed
occasionally [9]. PAS stain shows glycogen granules in the
cytoplasm of these clear cells, which is why they are
referred to as sugar tumors [5]. The clear cell tumor has
to be differentiated from other malignant clear-cell
tumors, particularly unusual primary clear cell adenocar-
cinoma of the lung and metastatic renal cell carcinoma,
both of which can have a bland morphologic appearance
and, therefore, can mimic CCTL. The tumor cells in both
primary and secondary clear cell adenocarcinomas of the
lung are positive for cytokeratin, whereas CCTL cells are
always non-reactive for cytokeratin [22]. In our case, the
diagnosis was based on the typical histology picture of
the tumor, the positivity for PAS and HMB-45, and the
absence of clinical signs of a renal tumor. We believe
that the joint application of these markers can distinguishCCTL from other pulmonary neoplasms with greater
precision [25].
Conclusions
In summary, we reported a case of CCTL and a litera-
ture review of 55 CCTL cases. We analyzed the patient’s
clinical characteristics, the tumor’s radiological features,
and the effects of CCTL tumor size. We conclude that
the tumor has three characteristics: (1) most of the
patients are middle-aged and elderly people (with
slightly more males than females) and are generally
asymptomatic; (2) the tumor, which is usually located in
both lower lungs, is round and homogeneous density on
plain CT scan image; and (3) tumors ≥2.2 cm in diameter
grow lobulated and have more aggressive symptoms.
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